Antibiotics, Antimicrobial
Best Rules To Handle Tough Bacteria Outbreaks
Mar
Tough bacteria outbreaks pose a significant threat to public health, challenging healthcare systems worldwide. These outbreaks are caused by bacteria that have developed resistance to multiple antibiotics, making them difficult to treat and control. The emergence of these tough bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA) and carbapenem-resistant Enterobacteriaceae (CRE), has led to increased morbidity, mortality, and healthcare costs.
To effectively handle tough bacteria outbreaks, healthcare professionals and public health agencies must implement a comprehensive approach that encompasses early detection, infection prevention and control measures, appropriate treatment strategies, and long-term prevention. This article provides an in-depth look at the best rules and practices for managing tough bacteria outbreaks, drawing upon the latest scientific evidence and expert recommendations to guide healthcare providers in their efforts to protect patients and communities from these dangerous pathogens.
Understanding Tough Bacteria Outbreaks
Defining Tough Bacteria and Their Characteristics
Tough bacteria, also known as antibiotic-resistant bacteria, are microorganisms that have developed resistance to multiple antibiotics, making them challenging to treat and control. These bacteria have acquired genetic mutations or gained resistance genes through various mechanisms, such as horizontal gene transfer, enabling them to survive and multiply in the presence of antibiotics that were once effective against them[1].
Common Types of Tough Bacteria Outbreaks
Several types of tough bacteria are responsible for outbreaks in healthcare settings and communities worldwide. Some of the most common include:
- Methicillin-resistant Staphylococcus aureus (MRSA)
- Vancomycin-resistant Enterococci (VRE)
- Carbapenem-resistant Enterobacteriaceae (CRE)
- Extended-spectrum beta-lactamase (ESBL) producing bacteria
These bacteria can cause a wide range of infections, from skin and soft tissue infections to life-threatening bloodstream infections and pneumonia[2].
Factors Contributing to the Emergence of Tough Bacteria
The emergence and spread of tough bacteria can be attributed to several factors, including:
- Overuse and misuse of antibiotics in healthcare and agriculture
- Inadequate infection prevention and control practices
- Increased global travel and migration
- Lack of new antibiotic development
Consequences of Tough Bacteria Outbreaks on Public Health
Tough bacteria outbreaks have severe consequences for public health, leading to increased morbidity and mortality, prolonged hospital stays, and higher healthcare costs. Patients infected with these bacteria often require treatment with second- or third-line antibiotics, which may be less effective, more toxic, and more expensive than first-line drugs[3].
Economic Impact of Tough Bacteria Outbreaks
In addition to their impact on patient outcomes, tough bacteria outbreaks also have significant economic consequences. The direct costs associated with treating these infections, such as increased hospital stays and the use of more expensive antibiotics, can be substantial. Moreover, the indirect costs, including lost productivity and the burden on healthcare systems, further compound the economic impact of these outbreaks.
Early Detection and Surveillance
Importance of Early Detection in Managing Tough Bacteria Outbreaks
Early detection plays a crucial role in managing tough bacteria outbreaks, as it allows healthcare providers to implement timely infection prevention and control measures, initiate appropriate treatment, and limit the spread of resistant organisms. Prompt identification of tough bacteria can help prevent the escalation of an outbreak and minimize its impact on patients and healthcare systems[4].
Surveillance Systems for Monitoring Tough Bacteria
Surveillance systems are essential for monitoring the emergence and spread of tough bacteria. These systems involve the systematic collection, analysis, and interpretation of data on antibiotic resistance patterns, outbreak occurrences, and risk factors. Effective surveillance systems should be comprehensive, covering both healthcare settings and the community, and should provide real-time data to guide public health interventions[5].
Laboratory Techniques for Identifying Tough Bacteria
Accurate and timely identification of tough bacteria is critical for guiding treatment decisions and implementing infection control measures. Laboratories play a vital role in this process, using various techniques such as:
- Culture-based methods
- Antimicrobial susceptibility testing
- Molecular diagnostic tests (e.g., PCR, whole-genome sequencing)
These techniques help characterize the resistance profiles of tough bacteria and inform the selection of appropriate antibiotic therapy[6].
Collaboration Between Healthcare Facilities and Public Health Agencies
Effective management of tough bacteria outbreaks requires close collaboration between healthcare facilities and public health agencies. Healthcare facilities should promptly report suspected or confirmed cases of tough bacteria to local public health authorities, who can then coordinate a broader response, including contact tracing, outbreak investigation, and dissemination of guidance to other healthcare providers.
Utilizing Technology for Rapid Detection and Response
Advances in technology have created new opportunities for rapid detection and response to tough bacteria outbreaks. Electronic health records, data analytics, and machine learning algorithms can help identify patterns and trends in antibiotic resistance, allowing for earlier detection of outbreaks. Additionally, mobile apps and web-based platforms can facilitate communication and data sharing among healthcare providers, enhancing the coordination of outbreak response efforts.
Infection Prevention and Control Measures
Hand Hygiene and Personal Protective Equipment (PPE)
Hand hygiene and the proper use of PPE are the cornerstones of infection prevention and control during tough bacteria outbreaks. Healthcare providers should perform hand hygiene using alcohol-based hand sanitizers or soap and water before and after every patient contact. They should also wear appropriate PPE, such as gloves, gowns, masks, and eye protection, when caring for patients with suspected or confirmed tough bacteria infections[7].
Isolation Precautions and Patient Cohorting
Patients with tough bacteria infections should be placed on appropriate isolation precautions, such as contact precautions, to prevent the spread of resistant organisms to other patients and healthcare providers. In outbreak situations, cohorting patients with the same type of tough bacteria can help contain the spread of infection and facilitate targeted infection control measures[8].
Environmental Cleaning and Disinfection
Thorough cleaning and disinfection of the healthcare environment, including patient rooms, medical equipment, and common areas, are essential for reducing the risk of tough bacteria transmission. Healthcare facilities should use EPA-registered disinfectants with proven efficacy against the specific tough bacteria involved in the outbreak and ensure that environmental services staff are properly trained in cleaning and disinfection protocols.
| Frequency | Products | Staff Training | |
|---|---|---|---|
| Patient Rooms | Daily and upon discharge | EPA-registered disinfectants | Proper cleaning techniques |
| Medical Equipment | After each use | Compatible disinfectants | Manufacturer guidelines |
Antimicrobial Stewardship Programs
Antimicrobial stewardship programs (ASPs) play a vital role in preventing the emergence and spread of tough bacteria by promoting the judicious use of antibiotics. ASPs involve a multidisciplinary team of healthcare professionals who work together to optimize antibiotic prescribing practices, reduce inappropriate antibiotic use, and minimize the selection pressure for antibiotic resistance[9].
Education and Training for Healthcare Providers
Ongoing education and training for healthcare providers are critical for ensuring compliance with infection prevention and control practices during tough bacteria outbreaks. Healthcare facilities should provide regular training sessions on hand hygiene, PPE use, isolation precautions, and environmental cleaning, as well as updates on the latest evidence-based guidelines for managing specific tough bacteria.
Treatment Strategies for Tough Bacteria Outbreaks
Determining Appropriate Antibiotic Therapy
Selecting appropriate antibiotic therapy is crucial for effectively treating patients infected with tough bacteria during outbreaks. Healthcare providers should rely on antibiotic susceptibility testing results to guide treatment decisions, as empiric therapy may not be effective against resistant organisms. In some cases, combination therapy with multiple antibiotics may be necessary to overcome resistance mechanisms and achieve optimal patient outcomes[10].
Utilizing Novel Antibiotics and Alternative Therapies
As traditional antibiotics become less effective against tough bacteria, the development and use of novel antibiotics and alternative therapies become increasingly important. Some examples include:
- New antibiotic classes with unique mechanisms of action
- Bacteriophage therapy
- Monoclonal antibodies
- Antimicrobial peptides
These alternative approaches may provide new options for treating infections caused by tough bacteria that are resistant to conventional antibiotics[11].
Implementing Antibiotic Cycling and Mixing Strategies
Antibiotic cycling and mixing are strategies that involve the planned rotation of different antibiotic classes or the simultaneous use of multiple antibiotics within a healthcare facility. These approaches aim to reduce the selection pressure for antibiotic resistance by limiting the prolonged exposure of bacteria to any single antibiotic. While the evidence for the effectiveness of these strategies is mixed, they may be useful in specific outbreak situations or in settings with high rates of antibiotic resistance.
Enhancing Infection Prevention and Control Measures
In addition to appropriate antibiotic therapy, enhancing infection prevention and control measures is essential for managing tough bacteria outbreaks. This includes:
- Strict adherence to hand hygiene and PPE use
- Proper isolation and cohorting of infected patients
- Thorough environmental cleaning and disinfection
- Active surveillance and screening for colonized patients
These measures can help break the chain of transmission and limit the spread of tough bacteria within healthcare facilities[12].
Monitoring Treatment Outcomes and Adverse Events
Close monitoring of treatment outcomes and adverse events is crucial during tough bacteria outbreaks. Healthcare providers should regularly assess patients’ clinical response to antibiotic therapy, monitor for signs of treatment failure or complications, and promptly report any suspected adverse drug reactions. This vigilance can help identify the need for adjustments in treatment plans and ensure the best possible outcomes for patients affected by tough bacteria infections.
Outbreak Management and Communication
Establishing an Outbreak Management Team
When a tough bacteria outbreak is suspected or confirmed, healthcare facilities should promptly establish an outbreak management team to coordinate the response. This multidisciplinary team should include representatives from infection prevention and control, clinical departments, laboratory services, environmental services, and hospital administration. The team’s primary responsibilities include assessing the scope of the outbreak, implementing control measures, and communicating with staff, patients, and external stakeholders[13].
Developing an Outbreak Management Plan
An effective outbreak management plan is essential for guiding the response to tough bacteria outbreaks. The plan should outline the specific roles and responsibilities of team members, as well as the steps to be taken in the event of an outbreak. Key components of an outbreak management plan include:
- Criteria for identifying and declaring an outbreak
- Procedures for implementing infection prevention and control measures
- Protocols for patient and staff screening and surveillance
- Guidelines for antibiotic stewardship and treatment
- Communication strategies for internal and external stakeholders
The plan should be regularly reviewed and updated based on new evidence, guidelines, and lessons learned from previous outbreaks.
Communicating with Healthcare Providers and Staff
Clear and timely communication with healthcare providers and staff is critical during tough bacteria outbreaks. The outbreak management team should provide regular updates on the status of the outbreak, changes in infection prevention and control protocols, and any new treatment guidelines. Communication channels may include email, intranet postings, staff meetings, and educational sessions. It is important to foster a culture of transparency and encourage staff to report any concerns or potential exposures promptly[14].
Notifying Patients and Families
Patients and their families have a right to be informed about tough bacteria outbreaks that may affect their care. The outbreak management team should develop a communication plan for notifying patients and families, which may include letters, phone calls, or in-person meetings. The information provided should be clear, accurate, and sensitive to the concerns and needs of patients and their loved ones. Healthcare facilities should also have mechanisms in place to address questions and provide support services as needed.
Collaborating with Public Health Authorities and Media
Tough bacteria outbreaks often require collaboration with local, state, and federal public health authorities. Healthcare facilities should promptly report suspected or confirmed outbreaks to the appropriate public health agencies and work closely with them to investigate the source of the outbreak, implement control measures, and communicate with the public. In some cases, media attention may be unavoidable, and healthcare facilities should have a plan for managing media inquiries and providing accurate, timely information to the public[15].
Antimicrobial Resistance and Stewardship
The Role of Antimicrobial Resistance in Tough Bacteria Outbreaks
Antimicrobial resistance is a major driver of tough bacteria outbreaks in healthcare settings. The overuse and misuse of antibiotics have led to the emergence and spread of resistant organisms, making infections increasingly difficult to treat. Tough bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and carbapenem-resistant Enterobacteriaceae (CRE), are often resistant to multiple classes of antibiotics, limiting treatment options and increasing the risk of adverse outcomes for patients[16].
Implementing Antimicrobial Stewardship Programs
Antimicrobial stewardship programs (ASPs) are essential for promoting the judicious use of antibiotics and preventing the spread of antimicrobial resistance. ASPs involve a multidisciplinary team of healthcare professionals, including infectious disease specialists, clinical pharmacists, and infection preventionists, who work together to optimize antibiotic prescribing practices. Key strategies of ASPs include:
- Developing and implementing evidence-based antibiotic prescribing guidelines
- Providing education and feedback to healthcare providers on antibiotic use
- Monitoring antibiotic consumption and resistance patterns
- Implementing prospective audit and feedback on antibiotic prescriptions
- Utilizing rapid diagnostic tests to guide antibiotic therapy
By reducing inappropriate antibiotic use and minimizing the selection pressure for resistance, ASPs can help prevent the emergence and spread of tough bacteria in healthcare settings[17].
Collaborating with Microbiology Laboratories
Collaboration between healthcare providers and microbiology laboratories is essential for effective antimicrobial stewardship and outbreak management. Microbiology laboratories play a crucial role in identifying resistant organisms, performing antibiotic susceptibility testing, and communicating results to healthcare providers in a timely manner. They can also provide valuable data on resistance patterns and trends, which can inform antibiotic prescribing guidelines and help detect emerging resistance threats.
Promoting Antibiotic Stewardship in the Community
While much of the focus on antimicrobial resistance and stewardship is in healthcare settings, promoting appropriate antibiotic use in the community is also important. Outpatient prescribing accounts for a significant proportion of antibiotic use, and inappropriate prescribing in this setting can contribute to the development and spread of resistance. Healthcare providers should educate patients and the public about the risks of antibiotic overuse and the importance of using antibiotics only when necessary[18].Encouraging vaccination, good hygiene practices, and infection prevention measures can also help reduce the need for antibiotics in the community.
Long-term Prevention Strategies
Investing in Research and Development
To effectively combat tough bacteria outbreaks in the long term, it is crucial to invest in research and development efforts aimed at discovering new antibiotics and alternative therapies. As resistance to existing antibiotics continues to rise, there is an urgent need for novel compounds with unique mechanisms of action. Governments, academic institutions, and pharmaceutical companies should collaborate to prioritize and fund research into new antimicrobial agents, diagnostic tools, and treatment strategies[19].
Strengthening Infection Prevention and Control Infrastructure
Robust infection prevention and control (IPC) infrastructure is essential for preventing the spread of tough bacteria in healthcare settings. This includes ensuring adequate staffing of IPC teams, providing ongoing education and training for healthcare workers, and investing in facility upgrades and maintenance to support effective IPC practices. Healthcare facilities should also regularly assess and update their IPC policies and procedures based on the latest evidence and guidelines, and ensure compliance through regular audits and feedback.
Promoting Antibiotic Stewardship Across Healthcare Settings
Antibiotic stewardship efforts should be expanded and integrated across all healthcare settings, including hospitals, long-term care facilities, and outpatient clinics. This requires a coordinated, multidisciplinary approach involving healthcare providers, pharmacists, and IPC professionals. Strategies for promoting antibiotic stewardship include implementing evidence-based prescribing guidelines, providing education and feedback to providers, and utilizing electronic health records and clinical decision support tools to optimize antibiotic use[20].
Enhancing Surveillance and Data Sharing
Effective surveillance and data sharing are critical for detecting and responding to tough bacteria outbreaks in a timely manner. Healthcare facilities should participate in local, regional, and national surveillance networks to monitor trends in antibiotic resistance and share data on emerging threats. This information can be used to inform prevention and control strategies, guide antibiotic prescribing practices, and allocate resources to areas of greatest need.
Engaging Patients and the Public
Engaging patients and the public as partners in preventing tough bacteria outbreaks is essential for long-term success. Healthcare providers should educate patients about the risks of antibiotic resistance, the importance of appropriate antibiotic use, and the role of infection prevention measures in reducing the spread of resistant organisms. Public health campaigns can also raise awareness about the threat of antibiotic resistance and promote behaviors that help prevent infections, such as hand hygiene and vaccination[21]. By empowering patients and the public to take an active role in their own health and the health of their communities, we can build a stronger, more resilient healthcare system better equipped to tackle the challenges posed by tough bacteria outbreaks.
Future Directions and Challenges
Developing New Diagnostic Technologies
Rapid and accurate diagnosis of tough bacteria infections is crucial for guiding appropriate treatment and preventing the spread of resistant organisms. In the future, the development of new diagnostic technologies, such as point-of-care tests and advanced molecular assays, could significantly improve our ability to detect and respond to tough bacteria outbreaks. These technologies should be designed to provide rapid, sensitive, and specific results, while also being cost-effective and easy to use in a variety of healthcare settings[22].
Exploring Alternative Therapies and Treatment Strategies
As antibiotic resistance continues to rise, there is a growing need for alternative therapies and treatment strategies to combat tough bacteria infections. This may include the development of novel antimicrobial agents, such as bacteriophages, antimicrobial peptides, and nanoparticles, as well as the use of combination therapies and adjunctive treatments to enhance the effectiveness of existing antibiotics. Additionally, the exploration of non-antibiotic approaches, such as immunotherapies and microbiome-based interventions, may offer new avenues for preventing and treating tough bacteria infections.
Addressing the Global Burden of Antibiotic Resistance
Antibiotic resistance is a global health threat that requires coordinated action at the local, national, and international levels. In the future, it will be essential to address the underlying drivers of resistance, such as the overuse and misuse of antibiotics in healthcare and agriculture, and to promote the development and implementation of effective antibiotic stewardship programs worldwide. This will require collaboration among governments, healthcare organizations, and industry partners to establish and enforce policies and guidelines for appropriate antibiotic use, as well as to support research and development efforts aimed at combating resistance[23].
Strengthening Infection Prevention and Control in Resource-Limited Settings
Tough bacteria outbreaks pose a particularly significant threat in resource-limited settings, where inadequate infection prevention and control infrastructure, limited access to diagnostic testing and appropriate antibiotics, and high rates of healthcare-associated infections can contribute to the rapid spread of resistant organisms. Strengthening infection prevention and control practices in these settings will require investments in healthcare infrastructure, training and education for healthcare workers, and the development of context-specific guidelines and interventions that are feasible and sustainable in low-resource environments.
Promoting Public Awareness and Engagement
Engaging the public as partners in the fight against antibiotic resistance and tough bacteria outbreaks is essential for driving change at the individual and societal levels. In the future, there will be a need for increased public awareness campaigns and educational initiatives to promote understanding of the risks associated with antibiotic overuse and misuse, as well as the importance of infection prevention measures and appropriate antibiotic stewardship. By empowering individuals to make informed decisions about their health and the use of antibiotics, we can create a culture of antibiotic stewardship that extends beyond the healthcare setting and into the broader community[24].
Frequently Asked Questions
Tough bacteria, also known as antibiotic-resistant bacteria, are strains of bacteria that have developed resistance to one or more antibiotics. This resistance makes infections caused by these bacteria more difficult to treat, as the antibiotics that would normally be effective against them are no longer able to kill or stop the growth of the bacteria.
Tough bacteria outbreaks can occur when resistant bacteria spread rapidly within a healthcare setting or community. This can happen due to improper infection control practices, overuse or misuse of antibiotics, or the introduction of a resistant strain into a susceptible population. Outbreaks can be particularly severe in healthcare settings, where patients may be more vulnerable to infections due to underlying medical conditions or weakened immune systems.
Some common types of tough bacteria include methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), carbapenem-resistant Enterobacteriaceae (CRE), and multidrug-resistant Pseudomonas aeruginosa. These bacteria can cause a range of infections, from skin and soft tissue infections to life-threatening bloodstream infections and pneumonia.
Healthcare facilities can prevent tough bacteria outbreaks by implementing robust infection prevention and control practices, such as proper hand hygiene, environmental cleaning and disinfection, and the use of personal protective equipment. Facilities should also have strong antimicrobial stewardship programs in place to promote the appropriate use of antibiotics and reduce the selection pressure for resistance.
Individuals can help prevent the spread of tough bacteria by practicing good hand hygiene, staying up to date with vaccinations, and only using antibiotics when prescribed by a healthcare provider and taking them exactly as directed. It is also important to follow any infection prevention guidelines when visiting healthcare facilities, such as wearing a mask or gown when required.
Developing new antibiotics to combat tough bacteria is challenging due to scientific, economic, and regulatory hurdles. Scientifically, finding new compounds that can effectively kill resistant bacteria without harming human cells is a complex and time-consuming process. Economically, the high costs of drug development and the limited market for new antibiotics can deter investment from pharmaceutical companies. Regulatory challenges include the need for clear pathways for antibiotic approval and appropriate incentives to encourage development.
Antibiotic stewardship involves the coordinated efforts to promote the appropriate use of antibiotics, improve patient outcomes, reduce antibiotic resistance, and decrease the spread of resistant infections. By optimizing antibiotic prescribing practices, healthcare providers can help preserve the effectiveness of existing antibiotics and reduce the selection pressure for resistance. This can be achieved through the development and implementation of evidence-based prescribing guidelines, provider education and feedback, and the use of diagnostic tools to guide treatment decisions.
Public awareness plays a crucial role in addressing the threat of tough bacteria and antibiotic resistance. By educating the public about the importance of appropriate antibiotic use, the risks of antibiotic overuse and misuse, and the need for infection prevention measures, we can create a culture of antibiotic stewardship that extends beyond healthcare settings. Public awareness campaigns can also help to build support for policies and investments aimed at combating antibiotic resistance and promoting the development of new antibiotics and alternative therapies.
Reference list
- World Health Organization. (2020). Antimicrobial resistance. https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance
- Centers for Disease Control and Prevention. (2019). Antibiotic resistance threats in the United States, 2019. U.S. Department of Health and Human Services, CDC.
- Cassini, A., Högberg, L. D., Plachouras, D., Quattrocchi, A., Hoxha, A., Simonsen, G. S., … & Monnet, D. L. (2019). Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. The Lancet Infectious Diseases, 19(1), 56-66.
- Shrivastava, S. R., Shrivastava, P. S., & Ramasamy, J. (2018). World Health Organization releases global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. Journal of Medical Society, 32(1), 76.
- Tacconelli, E., Carrara, E., Savoldi, A., Harbarth, S., Mendelson, M., Monnet, D. L., … & Zorzet, A. (2018). Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. The Lancet Infectious Diseases, 18(3), 318-327.
- Mulani, M. S., Kamble, E. E., Kumkar, S. N., Tawre, M. S., & Pardesi, K. R. (2019). Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance: a review. Frontiers in Microbiology, 10, 539.
- Santajit, S., & Indrawattana, N. (2016). Mechanisms of antimicrobial resistance in ESKAPE pathogens. BioMed Research International, 2016.
- Rice, L. B. (2008). Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. The Journal of Infectious Diseases, 197(8), 1079-1081.
- Liu, Y. Y., Wang, Y., Walsh, T. R., Yi, L. X., Zhang, R., Spencer, J., … & Shen, J. (2016). Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. The Lancet Infectious Diseases, 16(2), 161-168.
- Manohar, P., Loh, B., Athira, S., Nachimuthu, R., Hua, X., Welburn, S. C., & Leptihn, S. (2020). Secondary bacterial infections during pulmonary viral disease: phage therapeutics as alternatives to antibiotics?. Frontiers in Microbiology, 11, 1434.
- Torres-Barceló, C. (2018). The disparate effects of bacteriophages on antibiotic-resistant bacteria. Emerging Microbes & Infections, 7(1), 1-12.
- Gordillo Altamirano, F. L., & Barr, J. J. (2019). Phage therapy in the postantibiotic era. Clinical Microbiology Reviews, 32(2), e00066-18.
- Kortright, K. E., Chan, B. K., Koff, J. L., & Turner, P. E. (2019). Phage therapy: a renewed approach to combat antibiotic-resistant bacteria. Cell Host & Microbe, 25(2), 219-232.
- Czaplewski, L., Bax, R., Clokie, M., Dawson, M., Fairhead, H., Fischetti, V. A., … & Rex, J. H. (2016). Alternatives to antibiotics—a pipeline portfolio review. The Lancet Infectious Diseases, 16(2), 239-251.
- Ghosh, C., Sarkar, P., Issa, R., & Haldar, J. (2019). Alternatives to conventional antibiotics in the era of antimicrobial resistance. Trends in Microbiology, 27(4), 323-338.
- Theuretzbacher, U., Outterson, K., Engel, A., & Karlén, A. (2020). The global preclinical antibacterial pipeline. Nature Reviews Microbiology, 18(5), 275-285.
- Plackett, B. (2020). Why big pharma has abandoned antibiotics. Nature, 586(7830), S50-S52.
- Simpkin, V. L., Renwick, M. J., Kelly, R., & Mossialos, E. (2017). Incentivising innovation in antibiotic drug discovery and development: progress, challenges and next steps. The Journal of Antibiotics, 70(12), 1087-1096.
- Årdal, C., Balasegaram, M., Laxminarayan, R., McAdams, D., Outterson, K., Rex, J. H., & Sumpradit, N. (2020). Antibiotic development—economic, regulatory and societal challenges. Nature Reviews Microbiology, 18(5), 267-274.
- Burnham, C. A. D., Leeds, J., Nordmann, P., O’Grady, J., & Patel, J. (2017). Diagnosing antimicrobial resistance. Nature Reviews Microbiology, 15(11), 697-703.
- Kumar, A., & Chordia, N. (2017). Role of microbes in human health. Applied Microbiology: Open Access, 3(2), 131.
- Laxminarayan, R., Sridhar, D., Blaser, M., Wang, M., & Woolhouse, M. (2016). Achieving global targets for antimicrobial resistance. Science, 353(6302), 874-875.
- Sommer, M. O., Munck, C., Toft-Kehler, R. V., & Andersson, D. I. (2017). Prediction of antibiotic resistance: time for a new preclinical paradigm?. Nature Reviews Microbiology, 15(11), 689-696.
- Zetts, R. M., Stoesz, A., Smith, B. A., & Hyun, D. Y. (2018). Outpatient antibiotic use and the need for increased antibiotic stewardship efforts. Pediatrics, 141(6), e20174124.
